By Beth Winegarner ( August 17, 2015, 7:31 PM EDT) -- Drugstore chains accusing Boehringer Ingelheim Pharmaceuticals Inc. of scheming to keep generic versions of the stroke drug Aggrenox off the market shot back at the defendants' arguments that a recent ruling fails to bolster their case, telling a Connecticut federal court Monday that order supports their injunction bid....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.